INTERNATIONAL PATENT: MERGE THERAPEUTICS, INC. FILES APPLICATION FOR "BISPECIFIC ANTIBODIES AND METHODS OF USE THEREOF"

GENEVA, April 8 -- MERGE THERAPEUTICS, INC. (329 Oyster Point Blvd, 3rd FloorSouth San Francisco, California 94080) filed a patent application (PCT/US2025/048499) for "BISPECIFIC ANTIBODIES AND METHODS OF USE THEREOF" on Sep 29, 2025. With publication no. WO/2026/073139, the details related to the patent application was published on Apr 02, 2026.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): GEHMAN, Lauren T. (c/o Merge Therapeutics, Inc.329 Oyster Point Blvd, 3rd FloorSouth San Francisco, California 94080), YOUNGBLOOD, Bradford A. (c/o Merge Therapeutics, Inc.329 Oyster Point Blvd, 3rd FloorSou...